BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28319570)

  • 21. CXCL14-CXCR4 and CXCL12-CXCR4 Axes May Play Important Roles in the Unique Invasion Process of Endometrioid Carcinoma With MELF-Pattern Myoinvasion.
    Kojiro-Sanada S; Yasuda K; Nishio S; Ogasawara S; Akiba J; Ushijima K; Yano H
    Int J Gynecol Pathol; 2017 Nov; 36(6):530-539. PubMed ID: 28277316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microcystic elongated and fragmented (MELF) pattern of invasion: Molecular features and prognostic significance in the PORTEC-1 and -2 trials.
    van den Heerik ASVM; Aiyer KTS; Stelloo E; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Mens JWM; van der Steen-Banasik EM; Creutzberg CL; Smit VTHBM; Horeweg N; Bosse T
    Gynecol Oncol; 2022 Sep; 166(3):530-537. PubMed ID: 35840357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrioid endometrial carcinomas with microcystic, elongated, and fragmented (MELF) type of myoinvasion: role of immunohistochemistry in the detection of occult lymph node metastases and their clinical significance.
    Espinosa I; Serrat N; Zannoni GF; Rovira R; D'Angelo E; Prat J
    Hum Pathol; 2017 Dec; 70():6-13. PubMed ID: 28601659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MELF pattern of myometrial invasion and role in possible endometrial cancer diagnostic pathway: A systematic review of the literature.
    Prodromidou A; Vorgias G; Bakogiannis K; Kalinoglou N; Iavazzo C
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():147-152. PubMed ID: 30286364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium.
    Köbel M; Tessier-Cloutier B; Leo J; Hoang LN; Gilks CB; Soslow RA; Delair D; Stewart CJR; Lee CH
    Int J Gynecol Pathol; 2017 Nov; 36(6):555-561. PubMed ID: 28114191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel Nodal Metastasis Detection in Endometrial Carcinoma With Microcystic, Elongated, and Fragmented (MELF) Pattern by Cytokeratin Immunostaining.
    Rabe KM; Klein ME; Ghatak S; Stout I; Schefter A; Erickson BK; Khalifa MA
    Am J Clin Pathol; 2021 Oct; 156(5):846-852. PubMed ID: 34125164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma.
    Han G; Lim D; Leitao MM; Abu-Rustum NR; Soslow RA
    Histopathology; 2014 Feb; 64(3):389-98. PubMed ID: 24215212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas.
    Djordjevic B; Barkoh BA; Luthra R; Broaddus RR
    Mod Pathol; 2013 Oct; 26(10):1401-12. PubMed ID: 23599155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grossly unremarkable cervix in endometrial carcinomas: lymphovascular space invasion and microcystic elongated and fragmented pattern may be associated with high incidence of cervical stromal involvement.
    Zhang Y; Jeyachandran D; Desouki MM
    Hum Pathol; 2021 Jul; 113():59-66. PubMed ID: 33933559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma.
    Arciuolo D; Travaglino A; Santoro A; Scaglione G; D'Alessandris N; Valente M; Inzani F; Accarino R; Piermattei A; Benvenuto R; Raffone A; Nero C; Pelligra S; Fanfani F; Mascolo M; Zannoni GF
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Microcystic, elongated and fragmented invasive pattern in endometrial adenocarcinoma: a clinicopathologic analysis of 72 cases].
    Hu D; Zhang HJ; Shen WC; Zhu WF; Li L; Lin XD; Lu JP; Zheng XW; Wang C; Zhou XR
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):318-322. PubMed ID: 28468037
    [No Abstract]   [Full Text] [Related]  

  • 34. Strong expression of PD-L1 in invasive front of MELF pattern in endometrioid carcinoma.
    Tahara S; Kohara M; Sato K; Morii E
    Pathol Res Pract; 2022 Jan; 229():153699. PubMed ID: 34929601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MELF invasion in endometrial cancer as a risk factor for lymph node metastasis.
    Pavlakis K; Messini I; Vrekoussis T; Panoskaltsis T; Chrysanthakis D; Yiannou P; Voulgaris Z
    Histopathology; 2011 May; 58(6):966-73. PubMed ID: 21438907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].
    Jin W; Wang LQ; Liu Y; Liu AJ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):823-830. PubMed ID: 30585020
    [No Abstract]   [Full Text] [Related]  

  • 37. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin.
    Stewart CJ; Crook ML; Manso L
    Histopathology; 2011 Jul; 59(1):73-80. PubMed ID: 21771028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.
    Ruz-Caracuel I; López-Janeiro Á; Heredia-Soto V; Ramón-Patino JL; Yébenes L; Berjón A; Hernández A; Gallego A; Ruiz P; Redondo A; Peláez-García A; Mendiola M; Hardisson D
    Virchows Arch; 2021 Dec; 479(6):1167-1176. PubMed ID: 34420090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
    Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT
    Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MELF pattern invasion in endometrial carcinoma: association with low grade, myoinvasive endometrioid tumours, focal mucinous differentiation and vascular invasion.
    Stewart CJ; Brennan BA; Leung YC; Little L
    Pathology; 2009; 41(5):454-9. PubMed ID: 19900084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.